DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Solazyme (NASDAQ: SZYM)

3.15 0.01 (0.32%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SZYM $3.15 0.32%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.14
Previous Close $3.14
Daily Range $3.07 - $3.17
52-Week Range $2.00 - $12.44
Market Cap $252.2M
P/E Ratio -1.51
Dividend (Yield) $0.00 (0.0%)
Volume 364,258
Average Daily Volume 1,064,219
Current FY EPS -$1.72

Sector

Basic Materials

Industry

Chemicals

Solazyme (SZYM) Description

Solazyme Inc. is in the business of transforming a range of low-cost plant-based sugars into high-value oils. Website: http://www.solazyme.com/

News & Commentary

Can Biotech Save American Manufacturing?

Many think American manufacturing will remain globally noncompetitive for the foreseeable future, but biotech could change that in a big way.

Solazyme's AlgaVia Gains Traction As Bird Flu Leads To Possible Egg Shortage

Solazyme Provides A Progress Update On Moema

Trade-Ideas: Solazyme (SZYM) Is Today's Weak On High Relative Volume Stock

Solazyme Earnings Show Steady Progress Against 2015 Goals

Key takeaways from Solazyme’s first quarter 2015 earnings.

Solazyme's (SZYM) CEO Jonathan Wolfson on Q1 2015 Results - Earnings Call Transcript

Solazyme (SZYM) Q1 2015 Results - Earnings Call Webcast

2 Easy Ways Solazyme Can Unlock Value for Its Most Profitable Brand

Solazyme's Algenist brand is growing at a healthy clip, but the company can more fully monetize the manufacturing of the key ingredients. That's good news for investors.

Solazyme's Encapso: An Essential Ingredient In The American Shale Revolution

Solazyme Investors Await Moema Update, But This Is More Important

Think progress at Moema is the most critical information you'll receive during Solazyme's upcoming conference call? Think again.

See More SZYM News...

SZYM's Top Competitors

SZYM $3.15 (0.32%)
Current stock: SZYM
XOM $86.52 (-0.79%)
Current stock: XOM
PTR $124.77 (1.94%)
Current stock: PTR
RDS-B $62.23 (-1.78%)
Current stock: RDS-B